-
Systemic immunomodulation by irreversible electroporation versus stereotactic ablative body radiotherapy in locally advanced pancreatic cancer: the CROSSFIRE trial
Geboers, B., Timmer, F., Vos, D., Scheffer, H., Bakker, J., Ruarus, A., Vroomen, L., Stam, A., Lougheed, S., Schouten, E., Puijk, R., van den Tol, P., Lagerwaard, F., de Vries, J., Bruynzeel, A., Meijerink, M. & de Gruijl, T., 26 Mar 2025, In: J. Immunother. Cancer. 13, 3, e010222.Research output: Contribution to journal › Article › Academic › peer-review
-
MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE): a single-centre, open-label, randomised phase 2 trial
Timmer, F. E. F., Geboers, B., Ruarus, A. H., Vroomen, L. G. P. H., Schouten, E. A. C., van der Lei, S., Vos, D. J. W., Dijkstra, M., Schulz, H. H., Bakker, J., van den Bemd, B. A. T., van den Tol, P. M., Puijk, R. S., Lissenberg-Witte, B. I., de Gruijl, T. D., de Vries, J. J. J., Lagerwaard, F. J., Scheffer, H. J., Bruynzeel, A. M. E. & Meijerink, M. R., 1 May 2024, In: The Lancet Gastroenterology and Hepatology. 9, 5, p. 448-459 12 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Tissue Resistance Decrease during Irreversible Electroporation of Pancreatic Cancer as a Biomarker for the Adaptive Immune Response and Survival
Timmer, F. E. F., Geboers, B., Scheffer, H. J., Bakker, J., Ruarus, A. H., Dijkstra, M., van der Lei, S., Boon, R., Nieuwenhuizen, S., van den Bemd, B. A. T., Schouten, E. A. C., van den Tol, P. M., Puijk, R. S., de Vries, J. J. J., de Gruijl, T. D. & Meijerink, M. R., Oct 2023, In: Journal of vascular and interventional radiology. 34, 10, p. 1777-1784.e4Research output: Contribution to journal › Article › Academic › peer-review
- All publications
